Olswang has suffered a double exit with its co-head of life sciences departing the firm in favour of Clifford Chance, while Bond Dickinson has appointed another partner from the tech firm as its head of funds.
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact [email protected]
